Brabus, I didn't state that, however, some medicines can be bought at our Pharamacies where ,for 6 capsules a day, an entire 3 month course could set you back $400 odd.
Polyprenols I am finding hard to judge, however, as the company has only provided estimations, it is up to the market and laymen like us atm to estimate their future potential, projected pricing and marketing within each country that the product may be sold in. My replies to many on the day of their presentation and since were to perhaps state a different view,as a novice, to those who stated that the company may be worth $10 - $15 in a couple of years or will be the next CSL. IMO, when the company state contracts, markets, definitive pricing and their business plan in more detail, the company will be re-rated either way. IMO, I am also wary of any product which claims to have potentially enormous benefits across the vast array of human diseases.
Atm, I am leaving it up to the experts to work out as I am no Scientist. Who knows, if they can protect their IP and have a market where their general estimations are correct, it might be very lucrative on any scale.
NB. Nice to see Epitanman have context here and a curious mind.
This is my opinion only.
- Forums
- ASX - By Stock
- SLA
- natural pharmaceutical v other nat medicine
natural pharmaceutical v other nat medicine, page-17
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online